Skip to main content
. 2019 Aug;8(4):367–379. doi: 10.21037/tlcr.2019.08.16

Table 1. Characteristics of patients with metastatic lung cancer to bones.

Characteristics Total (n=13,541) Percent Population (n=96,107) Percent
Age, years
   0–64 4,940 36.48 33,993 35.37
   65–74 4,648 34.33 34,722 36.13
   75+ 3,953 29.19 27,392 28.50
Gender
   Male 7,827 57.80 48,975 50.96
   Female 5,714 42.20 47,132 49.04
Race
   Black 1,704 12.58 11,735 12.21
   White 11,837 87.42 84,372 87.79
Total number of in situ/malignant tumors for patient
   N=1 10,497 77.52 86,996 90.52
   N>1 3,044 22.48 9,111 9.48
Primary site
   Main bronchus 630 4.65 3,036 3.16
   Upper lobe 7,597 56.10 55,530 57.78
   Middle lobe 539 3.98 4,480 4.66
   Lower lobe 3,816 28.18 28,352 29.50
   Overlapping lesion of lung 130 0.96 1,127 1.17
   Lung, NOS 829 6.12 3,582 3.73
Histology
   Adenocarcinoma 6,679 49.32 38,730 40.30
   Squamous cell carcinoma 2,698 19.92 28,084 29.22
   SCLC 1,255 9.27 5,319 5.53
   NSCLC 1,086 8.02 4,773 4.97
   Other 1,823 13.46 19,201 19.98
Grade
   Grade I 636 4.70 11,272 11.73
   Grade II 3,245 23.96 32,806 34.13
   Grade III 8,485 62.66 46,669 48.56
   Grade IV 1,175 8.68 5,360 5.58
Tumor size
   0≤X≤3 2,781 20.54 40,545 42.19
   3<X≤5 4,332 31.99 26,098 27.16
   5<X≤7 3,199 23.62 15,496 16.12
   >7 3,229 23.85 13,968 14.53
Laterality
   Left-origin of primary 5,683 41.97 39,691 41.30
   Right-origin of primary 7,738 57.14 56,003 58.27
   Bilateral 120 0.89 413 0.43
Surgery performed
   Yes 463 3.42 42,481 44.20
   Unknown 18 0.13 416 0.43
   No 13,060 96.45 53,210 55.37
Radiation recode
   Yes 7,048 52.05 35,274 36.70
   No 6,493 47.95 60,833 63.30
Chemotherapy recode
   Yes 7,733 57.11 40,250 41.88
   No 5,808 42.89 55,857 58.12